IMUX FY 2021 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$135M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$92M

Net Income

-$93M

EPS (Diluted)

$-3.92

Cash Flow

Operating Cash Flow

-$83M

Free Cash Flow

-$83M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$139M

Total Liabilities

$12M

Stockholders' Equity

$127M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$92M	-$49M	-87.2%
Net Income	-$93M	-$44M	-111.2%